Cargando…
First case of postmortem study in a patient vaccinated against SARS-CoV-2
A previously symptomless 86-year-old man received the first dose of the BNT162b2 mRNA COVID-19 vaccine. He died 4 weeks later from acute renal and respiratory failure. Although he did not present with any COVID-19-specific symptoms, he tested positive for SARS-CoV-2 before he died. Spike protein (S1...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051011/ https://www.ncbi.nlm.nih.gov/pubmed/33872783 http://dx.doi.org/10.1016/j.ijid.2021.04.053 |
_version_ | 1783679679506415616 |
---|---|
author | Hansen, Torsten Titze, Ulf Kulamadayil-Heidenreich, Nidhi Su Ann Glombitza, Sabine Tebbe, Johannes Josef Röcken, Christoph Schulz, Birte Weise, Michael Wilkens, Ludwig |
author_facet | Hansen, Torsten Titze, Ulf Kulamadayil-Heidenreich, Nidhi Su Ann Glombitza, Sabine Tebbe, Johannes Josef Röcken, Christoph Schulz, Birte Weise, Michael Wilkens, Ludwig |
author_sort | Hansen, Torsten |
collection | PubMed |
description | A previously symptomless 86-year-old man received the first dose of the BNT162b2 mRNA COVID-19 vaccine. He died 4 weeks later from acute renal and respiratory failure. Although he did not present with any COVID-19-specific symptoms, he tested positive for SARS-CoV-2 before he died. Spike protein (S1) antigen-binding showed significant levels for immunoglobulin (Ig) G, while nucleocapsid IgG/IgM was not elicited. Acute bronchopneumonia and tubular failure were assigned as the cause of death at autopsy; however, we did not observe any characteristic morphological features of COVID-19. Postmortem molecular mapping by real-time polymerase chain reaction revealed relevant SARS-CoV-2 cycle threshold values in all organs examined (oropharynx, olfactory mucosa, trachea, lungs, heart, kidney and cerebrum) except for the liver and olfactory bulb. These results might suggest that the first vaccination induces immunogenicity but not sterile immunity. |
format | Online Article Text |
id | pubmed-8051011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80510112021-04-16 First case of postmortem study in a patient vaccinated against SARS-CoV-2 Hansen, Torsten Titze, Ulf Kulamadayil-Heidenreich, Nidhi Su Ann Glombitza, Sabine Tebbe, Johannes Josef Röcken, Christoph Schulz, Birte Weise, Michael Wilkens, Ludwig Int J Infect Dis Short Communication A previously symptomless 86-year-old man received the first dose of the BNT162b2 mRNA COVID-19 vaccine. He died 4 weeks later from acute renal and respiratory failure. Although he did not present with any COVID-19-specific symptoms, he tested positive for SARS-CoV-2 before he died. Spike protein (S1) antigen-binding showed significant levels for immunoglobulin (Ig) G, while nucleocapsid IgG/IgM was not elicited. Acute bronchopneumonia and tubular failure were assigned as the cause of death at autopsy; however, we did not observe any characteristic morphological features of COVID-19. Postmortem molecular mapping by real-time polymerase chain reaction revealed relevant SARS-CoV-2 cycle threshold values in all organs examined (oropharynx, olfactory mucosa, trachea, lungs, heart, kidney and cerebrum) except for the liver and olfactory bulb. These results might suggest that the first vaccination induces immunogenicity but not sterile immunity. The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-06 2021-04-16 /pmc/articles/PMC8051011/ /pubmed/33872783 http://dx.doi.org/10.1016/j.ijid.2021.04.053 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Hansen, Torsten Titze, Ulf Kulamadayil-Heidenreich, Nidhi Su Ann Glombitza, Sabine Tebbe, Johannes Josef Röcken, Christoph Schulz, Birte Weise, Michael Wilkens, Ludwig First case of postmortem study in a patient vaccinated against SARS-CoV-2 |
title | First case of postmortem study in a patient vaccinated against SARS-CoV-2 |
title_full | First case of postmortem study in a patient vaccinated against SARS-CoV-2 |
title_fullStr | First case of postmortem study in a patient vaccinated against SARS-CoV-2 |
title_full_unstemmed | First case of postmortem study in a patient vaccinated against SARS-CoV-2 |
title_short | First case of postmortem study in a patient vaccinated against SARS-CoV-2 |
title_sort | first case of postmortem study in a patient vaccinated against sars-cov-2 |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051011/ https://www.ncbi.nlm.nih.gov/pubmed/33872783 http://dx.doi.org/10.1016/j.ijid.2021.04.053 |
work_keys_str_mv | AT hansentorsten firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2 AT titzeulf firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2 AT kulamadayilheidenreichnidhisuann firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2 AT glombitzasabine firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2 AT tebbejohannesjosef firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2 AT rockenchristoph firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2 AT schulzbirte firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2 AT weisemichael firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2 AT wilkensludwig firstcaseofpostmortemstudyinapatientvaccinatedagainstsarscov2 |